Treatments for Central congenital hypothyroidism

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing data

FDA-approved treatments (0)

No FDA-approved treatments for Central congenital hypothyroidism are tracked on UniteRare yet. Clinical trials may be available — see the trials page.

Patient support programs (2)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

CINACALCET

Amgen

Secondary Hyperparathyroidism

Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications
1-888-427-7478

Paricalcitol

AbbVie

Secondary Hyperparathyroidism

Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications
1-800-222-6885

More about Central congenital hypothyroidism